Background: Anti -vascular endothelial growth factors are being widely used in the field of ophthalmology, with a variety of indications which are expanding over time Aim: To assess the frequency of different types of diseases treated with anti- VEGF agents. Method: A cross sectional study involving 100 patients, data included: age, gender, indication for anti- VEGF & presence or absence of diabetes. Results: The mean age was 57.7 years males represent 61% while females 39%, and the most common indication for intravitreal anti- VEGF was diabetic maculopathy with clinically significant macular odema (csmo) which represent 80% of cases, the second and third indications were vitreous hemorrhage 6% and wet type age related macular degeneration (AMD) 5%. Diabetes was present in 94% of all cases. Conclusion: Diabetes is the major risk factor causing varieties of retinal diseases that need intravitreal anti- VEGF agents, among which clinically significant macular odema is the most common pathology.
(FULL ARTICLE LINK) Read more ...
2019
|
|
|
